the pearl study: palbociclib and endocrine therapy vs capecitabine in hr /her2- metastatic breas...
Published 4 years ago • 158 plays • Length 8:40Download video MP4
Download video MP3
Similar videos
-
7:09
palbociclib endocrine therapy vs capecitabine for hr-positive her2-negative breast cancer: pearl
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
5:00
penelope-b: palbociclib with endocrine therapy in hr , her2-negative breast cancer
-
3:08
young-pearl: palbociclib plus exemestane and ofs in hr /her2- breast cancer
-
5:04
paloma-3: palbociclib and fulvestrant for hr-/her metastatic breast cancer
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
2:02
palbociclib combined with fulvestrant in relapsed metastatic hr /her2- breast cancer
-
2:43
adaptcycle: adjuvant personalised therapy comparing endocrine therapy plus ribociclib versus che...
-
1:29
capitello-292: capivasertib, palbociclib, and fulvestrant for hr endocrine-resistant breast cancer
-
2:21
palbociclib with adjuvant endocrine therapy in early breast cancer - pallas study
-
7:27
polaris: palbociclib for bipoc patients with her2-negative breast cancer
-
3:20
novel targeted drug palbociclib slows progression of hormone receptor-positive breast cancer
-
3:34
novel targeted drug palbociclib slows progression of hormone receptor-positive breast cancer
-
4:22
how to use endocrine therapy in premenopausal women with er metastatic breast cancer
-
39:21
bcfnz webinar: palbociclib (ibrance) for advanced or metastatic hr breast cancer - nz update
-
6:06
combination of eribulin and capecitabine provides clinical benefit for women with mbc
-
4:11
ribociclib plus endocrine therapy improves survival in premenopausal patients with metastatic br...
-
8:52
hr–positive advanced breast cancer: ribociclib improved pfs for pre and perimenopausal women